Evidence map›Paper›PMID 34882182›Full record

ArticleJAMA network open2021

Adverse Pregnancy Outcomes and Incident Heart Failure in the Women's Health Initiative.

Aleksander L Hansen, Marc Meller Søndergaard, Mark A Hlatky, Eric Vittinghof, Gregory Nah, Marcia L Stefanick, JoAnn E Manson, Leslie V Farland, Gretchen L Wells, Morgana Mongraw-Chaffin and 10 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women.Journal of the American College of Cardiology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Coronary Microvascular Function Following Severe Preeclampsia.Hypertension (Dallas, Tex. : 1979) · 2024
    Article
  17. Review
  18. Coronary Microvascular Function Following Severe Preeclampsia.medRxiv : the preprint server for health sciences · 2024
    Article
  19. Review
  20. A disease of her own? Unique features of heart failure in women.Climacteric : the journal of the International Menopause Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 2 countries.

Aleksander L HansenSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
Marc Meller SøndergaardAalborg University School of Medicine and Health, Aalborg, Denmark.
Mark A HlatkyDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
Eric VittinghofDepartment of Epidemiology and Biostatistics, University of California San Francisco School of Medicine, San Francisco.
Gregory NahDepartment of Medicine, Division of Cardiology, University of California, San Francisco.
Marcia L StefanickDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
JoAnn E MansonDepartment of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Leslie V FarlandMel and Enid Zuckerman College of Public Health, University of Arizona, Tucson.
Gretchen L WellsCollege of Medicine, University of Kentucky, Lexington.
Morgana Mongraw-ChaffinDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Erica P GundersonLifecourse Epidemiology of Diabetes and Heart Disease in Women and Youth Division of Research, Kaiser Permanente Northern California, Oakland.
Linda Van HornFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
Robert A WildDepartment of Biostatistics and Epidemiology, Oklahoma University Health Sciences Center, Oklahoma City.
Buyun LiuDepartment of Epidemiology, University of Iowa, Iowa City.
Aladdin H ShadyabSchool of Medicine, University of California San Diego, La Jolla.
Matthew A AllisonSchool of Medicine, University of California San Diego, La Jolla.
Simin LiuDepartment of Epidemiology, Public Health Program, Brown University, Providence, Rhode Island.
Charles B EatonAlpert Medical School, Brown University, Pawtucket, Rhode Island.
Michael C HonigbergCardiology Division, Massachusetts General Hospital, Boston.
Nisha I ParikhDepartment of Medicine, Division of Cardiology, University of California, San Francisco.
University of California, San Francisco · USBrown University · USStanford University · USUniversity of California, San Diego · USAalborg University · DKHarvard University · USKaiser Permanente · USMassachusetts Institute of Technology · USNorthwestern University · USOdense University Hospital · DKUniversity of Arizona · USUniversity of Iowa · USUniversity of Kentucky · USUniversity of Oklahoma Health Sciences Center · USWake Forest University · US

Funding

Noninvasive Cardiovascular Imaging Research Training ProgramT32HL094301 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Marcelo F DI CARLI · 2010 to 2026
$7.8M
NHLBI NIH HHS T32 HL094301
6 · The paper itself

Abstract

Importance: Some prior evidence suggests that adverse pregnancy outcomes (APOs) may be associated with heart failure (HF). Identifying unique factors associated with the risk of HF and studying HF subtypes are important next steps. Objective: To investigate the association of APOs with incident HF overall and stratified by HF subtype (preserved vs reduced ejection fraction) among postmenopausal women in the Women's Health Initiative (WHI). Design, Setting, and Participants: In 2017, an APO history survey was administered in the WHI study, a large multiethnic cohort of postmenopausal women. The associations of 5 APOs (gestational diabetes, hypertensive disorders of pregnancy [HDP], low birth weight, high birth weight, and preterm delivery) with incident adjudicated HF were analyzed. In this cohort study, the association of each APO with HF was assessed using logistic regression models and with HF subtypes using multinomial regression, adjusting for age, sociodemographic characteristics, smoking, randomization status, reproductive history, and other APOs. Data analysis was performed from January 2020 to September 2021. Exposures: APOs (gestational diabetes, HDP, low birth weight, high birth weight, and preterm delivery). Main Outcomes and Measures: All confirmed cases of women hospitalized with HF and HF subtype were adjudicated by trained physicians using standardized methods. Results: Of 10 292 women (median [IQR] age, 60 [55-64] years), 3185 (31.0%) reported 1 or more APO and 336 (3.3%) had a diagnosis of HF. Women with a history of any APO had a higher prevalence of hypertension, diabetes, coronary heart disease, or smoking. Of the APOs studied, only HDP was significantly associated with HF with a fully adjusted odds ratio (OR) of 1.75 (95% CI, 1.22-2.50), and with HF with preserved ejection fraction in fully adjusted models (OR, 2.06; 95% CI, 1.29-3.27). In mediation analyses, hypertension explained 24% (95% CI, 12%-73%), coronary heart disease 23% (95% CI, 11%-68%), and body mass index 20% (95% CI, 10%-64%) of the association between HDP and HF. Conclusions and Relevance: In this large cohort of postmenopausal women, HDP was independently associated with incident HF, particularly HF with preserved ejection fraction, and this association was mediated by subsequent hypertension, coronary heart disease, and obesity. These findings suggest that monitoring and modifying these factors early in women presenting with HDP may be associated with reduced long-term risk of HF.

Indexed as

AgedCohort StudiesFemaleHeart FailureHumansIncidenceLongitudinal StudiesMiddle AgedPostmenopausePregnancyPregnancy Complications, CardiovascularPregnancy OutcomeRisk FactorsUnited StatesWomen's Health

Identifiers

PMID34882182
PMCPMC8662370
OpenAlexW4200510253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.